Search results
Pfizer says it will no longer make a profit from selling its patented drugs to 1.2 billion people in...
Business Insider via Yahoo News· 2 years agoPfizer's initiative is titled "Accord for a Healthier World."Paul Hennessy/SOPA Images/LightRocket...
‘A vicious cycle’: Low Covid-19 vaccination rates lead to fewer doses at pediatric offices. Now,...
CNN via Yahoo News· 5 months agoLast year, days after the Moderna and Pfizer/BioNTech Covid-19 vaccines were authorized for...
Rare clotting effect of early COVID shots finally explained — what could that mean for future...
Live Science via Yahoo News· 5 months agoAn open box of astrazeneca vaccine vials, with one vial pulled out to show the label. Rare blood...
FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's Novavax
USA TODAY via Yahoo News· 2 years agoA federal vaccine advisory committee meets Tuesday to decide whether adult Americans could soon get...
What’s in the Novavax Vaccine? Experts Break It All Down
Prevention via Yahoo News· 2 years agoThe Food and Drug Administration has authorized Novavax’s COVID-19 vaccine for use in the U.S....
The Zacks Analyst Blog Highlights Pfizer, Booking Holdings, Dominion Energy, Marriott and Nutrien
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – June 20, 2022 – Zacks.com announces the list of stocks featured...
The U.S. has discarded over 82 million Covid vaccine doses, led by CVS and Walmart
NBC Universal via AOL· 2 years agoPharmacies, states, U.S. territories and federal agencies discarded 82.1 million Covid vaccine doses...
Is This Vaccine Stock a Buy After Big News?
Motley Fool· 2 years agoIt's hard to believe that more than two years after the onset of COVID-19 in the U.S., we're still seeing vaccines come to market. Of course, we...
mRNA creator studying vaccines' myocarditis risk
Yahoo Finance via AOL· 2 years agoThe co-creators of the mRNA technology used in both Pfizer (PFE)/BioNTech's (BNTX) and Moderna's (MRNA) COVID-19 vaccines are looking into the causes of...
Novavax's Shareholders Can Breathe a Sigh of Relief
Motley Fool· 2 years agoOn the other hand, Novavax finally cleared one of its most important (and long overdue) regulatory milestones. Let's discuss Novavax's recent regulatory...